Vanguard Group Inc Zivo Bioscience, Inc. Transaction History

Vanguard Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.18 - $2.52 $17,152 - $36,630	14,536 Added 12.5%	130,866 $170,000
Q2 2023 Aug 14, 2023	BUY	$2.22 - $3.41 $15,520 - $23,839	6,991 Added 6.39%	116,330 $281,000
Q1 2023 May 15, 2023	BUY	$2.33 - $3.64 $22,211 - $34,700	9,533 Added 9.55%	109,339 $336,000
Q4 2022 Feb 10, 2023	BUY	$2.48 - $19.98 $2,787 - $22,457	1,124 Added 1.14%	99,806 $249,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $23.64 $2,074 - $52,173	2,207 Added 2.29%	98,682 $276,000
Q2 2022 Aug 12, 2022	BUY	$2.61 - $4.03 $10,458 - $16,148	4,007 Added 4.33%	96,475 $378,000
Q1 2022 May 13, 2022	BUY	$2.44 - $4.27 $36,958 - $64,677	15,147 Added 19.59%	92,468 $359,000
Q4 2021 Feb 14, 2022	BUY	$2.73 - $4.48 $211,086 - $346,398	77,321 New	77,321 $221,000

Ticker ZIVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,419,660
Market Cap $164M
Description
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietar...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.